Review
Open access
Oct 2026
Considerations for therapeutic targets for clinical trials in biomarker-characterized prodromal Parkinson's disease populations
Parkinson's disease (PD) is a growing public health problem and biologically targeted therapeutics (BTTs) that slow disease progression are urgently needed. However, the development of effective BTTs is challenging as PD is a clinically defined syndrome with pathobiological heterogeneity and the pathobiological process...
R. Schneider, G. Skibinski, B. Fiske et al.
· Journal of Parkinson's Disea... · 0 citations